当前位置:
X-MOL 学术
›
JAMA Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment.
JAMA Oncology ( IF 28.4 ) Pub Date : 2021-11-01 , DOI: 10.1001/jamaoncol.2021.4390 Noa Eliakim-Raz 1, 2, 3 , Amir Massarweh 4 , Amos Stemmer 5 , Salomon M Stemmer 3, 4
中文翻译:
积极抗癌治疗患者对 SARS-CoV-2 BNT162b2 疫苗接种反应的持久性。
更新日期:2021-08-11
JAMA Oncology ( IF 28.4 ) Pub Date : 2021-11-01 , DOI: 10.1001/jamaoncol.2021.4390 Noa Eliakim-Raz 1, 2, 3 , Amir Massarweh 4 , Amos Stemmer 5 , Salomon M Stemmer 3, 4
Affiliation
中文翻译:
积极抗癌治疗患者对 SARS-CoV-2 BNT162b2 疫苗接种反应的持久性。